MediWound (MDWD) Profit After Tax (2013 - 2026)
MediWound (MDWD) posted quarterly Profit After Tax of -$7.2 million for Q4 2025, down 83.8% year-over-year from -$44.3 million in Q4 2024, and down 170.85% quarter-over-quarter from -$2.7 million in Q3 2025.
MediWound (MDWD) Profit After Tax (2013 - 2026) Analysis & Trends
MediWound's Profit After Tax history runs 13 years deep, the most recent figure standing at -$7.2 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 83.8% year-over-year to -$7.2 million; the TTM figure through Dec 2025 stood at -$23.9 million (up 20.99% YoY), while the FY2025 annual figure was -$23.9 million, up 20.99% from the prior year.
- Profit After Tax for Q4 2025 stood at -$7.2 million, down from -$2.7 million in the prior quarter.
- The five-year high for Profit After Tax was $916000.0 in Q2 2023, with the low at -$13.3 million in Q2 2025.
- The 5-year median for Profit After Tax is -$3.8 million (2023), against an average of -$4.7 million.
- The sharpest annual moves came in 2023 and 2024: Profit After Tax soared 121.04% in 2023, then sank 788.32% in 2024.
- MediWound's Profit After Tax stood at -$4.2 million in 2021, then sank by 79.25% to -$7.5 million in 2022, then jumped by 76.63% to -$1.7 million in 2023, then plunged by 124.21% to -$3.9 million in 2024, then slumped by 83.8% to -$7.2 million in 2025.
- Business Quant data shows MDWD's Profit After Tax at -$7.2 million in Q4 2025, -$2.7 million in Q3 2025, and -$13.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | -7.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.39 Mn |
| Dec 31, 2025 | -7.18 Mn |
| Sep 30, 2025 | -2.65 Mn |
| Jun 30, 2025 | -13.32 Mn |
| Mar 31, 2025 | -726,000.00 |
| Dec 31, 2024 | -3.91 Mn |
| Sep 30, 2024 | -10.28 Mn |
| Jun 30, 2024 | -6.31 Mn |
| Mar 31, 2024 | -9.73 Mn |
| Dec 31, 2023 | -1.74 Mn |
| Sep 30, 2023 | -2.20 Mn |
| Jun 30, 2023 | 916,000.00 |
| Mar 31, 2023 | -3.69 Mn |
| Dec 31, 2022 | -7.46 Mn |
| Sep 30, 2022 | -4.20 Mn |
| Jun 30, 2022 | -4.35 Mn |
| Mar 31, 2022 | -3.59 Mn |
| Dec 31, 2021 | -4.16 Mn |
| Sep 30, 2021 | -3.35 Mn |
| Jun 30, 2021 | -3.20 Mn |